Stockscreener 앱 받기
6.56
0.15%
0.010
시간 외 거래:
6.56
전일 마감가:
$6.55
열려 있는:
$6.52
하루 거래량:
292.60K
Relative Volume:
0.83
시가총액:
$438.81M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-10.93
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
-2.24%
1개월 성능:
-6.55%
6개월 성능:
-10.63%
1년 성능:
-51.69%
1일 변동 폭
$6.50
$6.75
1주일 범위
$6.50
$7.15
52주 변동 폭
$5.81
$14.38
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.56 | 438.14M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
Is Bioventus Inc. stock attractive for income investors2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
How strong is Bioventus Inc. stock revenue growth2025 Earnings Impact & Reliable Price Action Trade Plans - newser.com
What To Expect From Bioventus Inc (BVS) Q3 2025 Earnings - Yahoo Finance
Will Bioventus Inc. stock deliver long term returns2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Developing predictive dashboards with Bioventus Inc. dataPortfolio Value Report & Accurate Buy Signal Notifications - newser.com
What the charts say about Bioventus Inc. today2025 Earnings Impact & Momentum Based Trading Ideas - newser.com
Can Bioventus Inc. rally from current levelsLayoff News & Free Community Supported Trade Ideas - newser.com
Bioventus Inc. stock prediction for this weekLong Setup & Accurate Entry/Exit Alerts - newser.com
Bioventus Inc. stock chart pattern explained2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com
Should you wait for a breakout in Bioventus Inc.Earnings Risk Report & Step-by-Step Trade Execution Guides - newser.com
Will Bioventus Inc. stock maintain momentum in 2025July 2025 Intraday Action & AI Forecasted Entry and Exit Points - newser.com
Can Bioventus Inc. stock sustain free cash flow growth2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Short interest data insights for Bioventus Inc.July 2025 PostEarnings & Weekly Top Gainers Trade List - newser.com
Why Bioventus Inc. stock is trending among retail tradersBond Market & Capital Efficiency Focused Ideas - newser.com
Detecting price anomalies in Bioventus Inc. with AIInflation Watch & Technical Pattern Alert System - newser.com
Backtesting results for Bioventus Inc. trading strategiesEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
Is Bioventus Inc. stock recession proofQuarterly Profit Report & AI Powered Market Entry Ideas - newser.com
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 - The Manila Times
Bioventus (NASDAQ: BVS) to report Q3 FY2025 before open; 8:30 a.m. ET call - Stock Titan
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.40%
자본화:
|
볼륨(24시간):